|
|
 |
|
Viewing report
|
|
|
|
Cytokine Therapies
John Wiley and Sons Ltd, Feb 2010, Pages: 252
Cytokines are protein messengers responsible for cellular communication with great therapeutic potential to control inflammatory and immune disorders such us cancer, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease. Despite the solid scientific rationale for this therapeutic promise, many cytokine-related therapies have failed to establish clinical utility.
In March 2009, international experts from academia, industry and government convened to discuss the scientific and clinical basis for the successes and failures of recombinant cytokines and cytokine antagonists as therapeutic agents, and possible strategies for improving their clinical success. This volume included extended versions of key presentations at the meeting.
Participants examined:
- Improved methods for identifying disease targets
- Alternative methods for enhancing and targeting cytokine delivery
- Physicochemical modification of cytokines to prolong their bioavailability
Customers who bought this item also bought
Contemporary Targeted Therapies in Rheumatology
Nitric Oxide - Therapeutics, Markets and Companies
Crohn’s Disease: Future Treatment Scenarios and Opportunities
Delivering RNAi-Based Therapeutics & Diagnostics: Challenges & Opportunities
Immune/Inflammatory Disease: Early-Stage R&D Technologies and Dealmaking
Pipeline Insight: Inflammatory Bowel Disease - Varied drug targets to broaden future therapy options
Preclinical Cancer Therapeutics 2007: Decoding Next Generation Drug Targets for Market Success
Crohn's Disease: KOL Insights on Treatment Practices and Unmet Needs
Special Report: The Autoimmune Biologics Pipeline-A Competitive Review
Current Treatments, Unmet Needs, and Opportunities in Treating Pediatric Crohn’s Disease
|
|
|
|
